New Study Points to Longer Duration of Axillary Lymphadenopathy After COVID-19 Vaccine
While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.